6960 N Stock Overview
Engages in the manufacture and sale of medical instruments in Japan and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Fukuda Denshi Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,032.13 |
52 Week High | JP¥1,032.13 |
52 Week Low | JP¥1,032.13 |
Beta | 0.22 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
6960 N | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how 6960 N performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how 6960 N performed against the MX Market.
Price Volatility
6960 N volatility | |
---|---|
6960 N Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: 6960 N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine 6960 N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1939 | 3,443 | Kotaro Fukuda | fukuda.com |
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. Fukuda Denshi Co., Ltd.
Fukuda Denshi Co., Ltd. Fundamentals Summary
6960 N fundamental statistics | |
---|---|
Market cap | Mex$28.85b |
Earnings (TTM) | Mex$2.20b |
Revenue (TTM) | Mex$18.35b |
13.3x
P/E Ratio1.6x
P/S RatioIs 6960 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6960 N income statement (TTM) | |
---|---|
Revenue | JP¥138.10b |
Cost of Revenue | JP¥66.88b |
Gross Profit | JP¥71.22b |
Other Expenses | JP¥54.63b |
Earnings | JP¥16.59b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 575.45 |
Gross Margin | 51.57% |
Net Profit Margin | 12.01% |
Debt/Equity Ratio | 1.0% |
How did 6960 N perform over the long term?
See historical performance and comparison